Montpellier, France

Dominique Olliero

This inventor holds 16 USPTO granted patents. Top assignees: Sanofi, Elf Sanofi, Choay, S.a.. Active years: 1986-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dominique Olliero. Retrieved from https://idiyas.com/inventor/dominique-olliero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 155(Granted Patents)


Company Filing History:


Years Active: 1986-2002

Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dominique Olliero

Introduction

Dominique Olliero is a prominent inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 16 patents. His work focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the Carboxamidothiazole derivatives, which include preparations and pharmaceutical compositions containing them. Additionally, he has developed pyridazine derivatives that serve as ligands for cholinergic receptors, particularly the M1 type. These innovations highlight his commitment to advancing medical science through his research.

Career Highlights

Throughout his career, Dominique Olliero has worked with notable companies such as Sanofi and Elf Sanofi. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Dominique has collaborated with esteemed colleagues, including Roger Brodin and Robert Boigegrain. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful inventions.

Conclusion

Dominique Olliero's work exemplifies the spirit of innovation in the pharmaceutical field. His numerous patents and collaborations reflect his dedication to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…